Arvee Laboratories (India) Ltd Financials
Company Logo

Arvee Laboratories (India) Ltd Financial Statement

Arvee Laboratories (India) Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue12.68
Operating Expense11.02
Net Profit0.98
Net Profit Margin7.73
Earning Per Share0.89
EBIDTA1.66
Effective Tax Rate19.88
Invest in Arvee Laboratories (India) Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Arvee Laboratories (India) Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual30.35
Operating Expenses Annual27.41
Operating Profit Annual3.58
Interest Annual0.25
Depreciation1.50
Net Profit Annual1.05
Tax Annual0.78

Arvee Laboratories (India) Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.54
Cash Flow from Operations3.66
Cash Flow from Investing-2.16
Cash Flow from Financing-0.19
Cash Flow at the End1.85

Arvee Laboratories (India) Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)11.80
PBIT Margin (%)6.85
PBT Margin (%)-20.56
Net PROFIT Margin (%)3.46
Return On Networth / Equity (%)3.67
Return On Networth /Employed (%)6.96
Return On Assets (%)3.53
Total Debt / Equity (X)0.04
Asset Turnover Ratio (%)1.02

Arvee Laboratories (India) Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual12.67
Total Current Assets Annual16.79
Non Current Assets Annual21.41
Total Shareholders Funds Annual29.11
Total Assets Annual38.20

Arvee Laboratories (India) Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, Arvee Laboratories (India) Ltd has a market capitalization of 158.03 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Arvee Laboratories (India) Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Arvee Laboratories (India) Ltd recorded a total revenue of approximately 30.35 Cr marking a significant milestone in the company's financial performance.
Arvee Laboratories (India) Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.1% annually, respectively..
Arvee Laboratories (India) Ltd's current PE ratio is 150.50.
Arvee Laboratories (India) Ltd's ROCE averaged 14.4% from the FY ending March 2022 to 2024, with a median of 14.1%. It peaked at 22.3% in March 2023, reflecting strong capital efficiency over the period..
Arvee Laboratories (India) Ltd's latest EBIT is Rs. 2.08 Cr, surpassing the average EBIT of Rs. 4.15 Cr over the 5 years..